MCK McKesson Corporation
$790.44▲ +0.79%
Healthcare
Other
Last sync: just now
Syncing
Key Metrics & Fundamentals
Market Cap
$95.01B
P/E Ratio
20.6
Div Yield
0.42%
52W Range
637.00 - 999.00
% vs 50 MA
-2.26%
% vs 200 MA
-4.46%
RSI-14
54.8
MACD Histogram
+7.0800
Beta (1Y vs SPY)
-0.10
Free Cash Flow
$3.24B
Gross Rev
$96.30B
Gross Profit
$4.04B
EBITDA
$2.47B
COGS
$92.25B
Operating Exp
$1.80B
Operating Income
$2.25B
EBIT
$2.25B
Pretax Income
$2.13B
Net Income
$1.68B
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
Mar 2026 (Quarterly)
Social Sentiment
Avg +0.18 · 10 posts
DiscussionTrade9 oversold alerts in S&P today. AMD up 82% vs market in 20 days
r/StockMarket · May 11, 2026
Identified as an oversold stock, indicating potential for a rebound.
positive
+0.30
DiscussionTradeSeeing fairly wide dispersion in short-term moves across some mid and large-cap names recently
r/stocks · May 8, 2026
Discussed as declining noticeably, indicating negative sentiment.
negative
-0.60
DiscussionTradehealth care still oversold but starting to stabilize. semis overbought for days now
r/StockMarket · May 8, 2026
The post discusses a positive movement in MCK's RSI and suggests it's starting to recover.
positive
+0.30
DiscussionTradeanyone else notice health care getting wrecked today? COR and MCK RSI under 17
r/StockMarket · May 7, 2026
Similar to COR, MCK's RSI is highlighted negatively.
negative
+0.30
MCK vs MSFT valuation
r/stocks · Feb 12, 2026
The comments highlight MCK's strong performance and favorable characteristics, indicating a positive sentiment towards the stock.
positive
+0.60
Page 1 of 2 (10 total)
AI Analysis
Generated May 25, 8:23 PM
Company Overview
McKesson Corporation is a global leader in healthcare supply chain management, distributing pharmaceuticals and medical-surgical products, and providing healthcare information technology solutions. Its extensive distribution network and operational scale provide a significant competitive advantage in the highly regulated and complex healthcare sector.
Bull Case
- Defensive Industry: As a critical healthcare distributor, MCK operates in a non-discretionary sector, providing stable demand and defensive characteristics, particularly during economic downturns.
- Market Leadership & Scale: McKesson holds a dominant position in healthcare distribution, leveraging its vast network and purchasing power to achieve economies of scale and maintain competitive advantages.
- Diversified Offerings: Beyond pharmaceutical distribution, MCK's segments include medical-surgical distribution and healthcare technology solutions, diversifying revenue and reducing reliance on a single product line.
- Consistent Cash Flow: The essential nature of its services typically leads to strong, predictable cash flow generation, which can support strategic investments, dividends, or share buybacks.
Bear Case
- Regulatory & Reimbursement Risk: The healthcare industry is heavily regulated, and changes in drug pricing policies, reimbursement models, or government mandates could negatively impact McKesson's margins and business model.
- Competitive Pressure: McKesson operates in a highly competitive environment with other large distributors, which can lead to margin compression and pricing pressure.
- Supply Chain Vulnerabilities: Disruptions in the global supply chain, such as manufacturing issues, geopolitical events, or pandemics, could impact product availability and distribution efficiency.
- Opioid Litigation Legacy: While significant settlements have occurred, the ongoing legacy of opioid-related litigation and potential future liabilities or reputational damage remains a risk factor.
Recent Performance
MCK has experienced a significant pullback, trading 23.3% below its 52-week high at $766.08. The stock is currently below both its 50-day and 200-day moving averages by 8.2% and 6.2% respectively, indicating a clear downtrend in the short to medium term. The RSI-14 at 41.3 suggests weak momentum, nearing oversold conditions but implying potential for further consolidation or downside before a strong rebound.
AI-generated analysis is for informational purposes only and does not constitute financial advice.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.